Velo-cardio-facial Syndrome. Download PDF information sheet. Back to Craniofacial Anomalies. What is Velo-cardio-facial Syndrome? Velocardiofacial Syndrome, also known as VCFS or as 22q11.2 Syndrome or as DiGeorge Syndrome, is the most common syndrome associated with cleft palate. Approximately 1 in 2,000-5,000 children are born with VCFS. VCFS is also called the 22q11.2 deletion syndrome. It also has other clinical names such as DiGeorge syndrome, conotruncal anomaly face syndrome (CTAF), autosomal dominant Opitz G/BBB syndrome or Cayler cardiofacial syndrome. As a result of this deletion, about 30 genes are generally absent from this chromosome. VCFS affects about 1 in 4,000.
DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a syndrome caused by the deletion of a small segment of chromosome 22. While the symptoms can vary, they often include congenital heart problems, specific facial features, frequent infections, developmental delay, Causes: Genetic (typically new mutation). Feb 13, 2014 · Velocardiofacial syndrome (VCFS) is a genetic condition characterized by abnormal pharyngeal arch development that results in defective development of the parathyroid glands, thymus, and conotruncal region of the heart. Shprintzen and colleagues first described the syndrome in 1978.
Velo-cardio-facial syndrome is one of the names that has been attached to one of the most common multiple anomaly syndromes in humans. The labels DiGeorge sequence, 22q11 deletion syndrome, conotruncal anomalies face syndrome, CATCH 22, and Sedlačková syndrome have all been attached to the same disorder.Cited by: 461. Velocardiofacial Syndrome - Pictures, What is, Symptoms, Treatment, Causes, Treatment. VCFS is a genetic health problem which can appear hereditary.
DiGeorge Syndrome, Online Mendelian Inheritance in Man (OMIM) History of the 22q11.2 Deletion, DM McDonald-McGinn and EH Zackai; Medical needs of children with the 22q11.2 deletion, 22q and You, Children's Hospital of Philadelphia; Velo-Cardio-Facial Syndrome Research Institute Closed July 2002. 22q11 causing velo-cardio-facial syndrome and DiGeorge syndrome. The study involves determining how the two chromosome 22's interacted during the stage of egg/sperm development termed meiosis. Deficiencies in this process may result in a deletion or duplication of chromosomal material (genes).
Velo-cardio-facial syndrome (VCFS) has drawn much attention since 1992 when there were simultaneous reports of a high prevalence of psychiatric illness, especially schizophrenia, as a clinical feature and the discovery of its cause, a deletion from chromosome 22 (Scambler et al., 1992).Prior to 1992, VCFS had received relatively little attention in the medical literature, but after 1992 Cited by: 58. What is Velo-Cardio-Facial Syndrome? Velo-Cardio-Facial syndrome (VCFS) is a genetic, autosomal dominant condition defined by Shprintzen in 1978. Its frequency is estimated at 1 per 4000 live births. In most patients, a deletion (Figure 2) on chromosome 22q11.2 (Figure .